In the realm of biomedical sciences, Singapore is an internationally recognised benchmark for innovation and strategic advancement. Driven by a steadfast commitment to research, digital transformation, and cutting-edge technologies, Singapore has firmly established itself as a global leader in drug discovery and development.
Spearheading this transformative journey is a collaborative ecosystem fueled by government support, business partnerships, and a relentless pursuit of excellence. Dr Hao Weidong, Chief Scientific Officer at the Experimental Drug Development Centre (EDDC), elaborates on Singapore’s unified mission to advance drug discovery and development to unprecedented heights.
